Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Zoledronate rescues immunosuppressed monocytes in sepsis patients.

Raffray L, Burton RJ, Baker SE, Morgan MP, Eberl M.

Immunology. 2019 Oct 13. doi: 10.1111/imm.13132. [Epub ahead of print]

PMID:
31606902
2.

γδ T cells in rheumatic diseases: from fundamental mechanisms to autoimmunity.

Nguyen CT, Maverakis E, Eberl M, Adamopoulos IE.

Semin Immunopathol. 2019 Sep;41(5):595-605. doi: 10.1007/s00281-019-00752-5. Epub 2019 Sep 10. Review.

PMID:
31506867
3.

Using artificial intelligence to reduce diagnostic workload without compromising detection of urinary tract infections.

Burton RJ, Albur M, Eberl M, Cuff SM.

BMC Med Inform Decis Mak. 2019 Aug 23;19(1):171. doi: 10.1186/s12911-019-0878-9.

4.

Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis.

Brook AC, Jenkins RH, Clayton A, Kift-Morgan A, Raby AC, Shephard AP, Mariotti B, Cuff SM, Bazzoni F, Bowen T, Fraser DJ, Eberl M.

Sci Rep. 2019 Jul 12;9(1):10136. doi: 10.1038/s41598-019-46585-y.

5.

Analysis of the Ribonuclease A Superfamily of Antimicrobial Peptides in Patients Undergoing Chronic Peritoneal Dialysis.

Pottanat ND, Brook AC, Bartosova M, Cortado H, Gupta S, Li B, Jackson AR, Vonau M, Cohen S, Ferrara M, Ching CB, Spencer JD, Brauner A, Fraser DJ, Schmitt CP, Eberl M, Ayoob R, Becknell B.

Sci Rep. 2019 May 23;9(1):7753. doi: 10.1038/s41598-019-44219-x.

6.

Cilia-Associated Oxysterols Activate Smoothened.

Raleigh DR, Sever N, Choksi PK, Sigg MA, Hines KM, Thompson BM, Elnatan D, Jaishankar P, Bisignano P, Garcia-Gonzalo FR, Krup AL, Eberl M, Byrne EFX, Siebold C, Wong SY, Renslo AR, Grabe M, McDonald JG, Xu L, Beachy PA, Reiter JF.

Mol Cell. 2018 Oct 18;72(2):316-327.e5. doi: 10.1016/j.molcel.2018.08.034.

7.

Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.

Nivarthi H, Gordziel C, Themanns M, Kramer N, Eberl M, Rabe B, Schlederer M, Rose-John S, Knösel T, Kenner L, Freund P, Aberger F, Han X, Kralovics R, Dolznig H, Jennek S, Friedrich K, Moriggl R.

Oncotarget. 2018 Sep 18;9(73):33865. doi: 10.18632/oncotarget.26156. eCollection 2018 Sep 18.

8.

Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.

Sternberg C, Gruber W, Eberl M, Tesanovic S, Stadler M, Elmer DP, Schlederer M, Grund S, Roos S, Wolff F, Kaur S, Mangelberger D, Lehrach H, Hache H, Wierling C, Laimer J, Lackner P, Wiederstein M, Kasper M, Risch A, Petzelbauer P, Moriggl R, Kenner L, Aberger F.

Int J Cancer. 2018 Dec 1;143(11):2943-2954. doi: 10.1002/ijc.31724. Epub 2018 Oct 1.

9.

Human γδ T-Cell Control of Mucosal Immunity and Inflammation.

McCarthy NE, Eberl M.

Front Immunol. 2018 May 7;9:985. doi: 10.3389/fimmu.2018.00985. eCollection 2018. Review.

10.

Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters.

Rhodes DA, Chen HC, Williamson JC, Hill A, Yuan J, Smith S, Rhodes H, Trowsdale J, Lehner PJ, Herrmann T, Eberl M.

Front Immunol. 2018 Apr 4;9:662. doi: 10.3389/fimmu.2018.00662. eCollection 2018.

11.

γδ T cell responses: How many ligands will it take till we know?

Vermijlen D, Gatti D, Kouzeli A, Rus T, Eberl M.

Semin Cell Dev Biol. 2018 Dec;84:75-86. doi: 10.1016/j.semcdb.2017.10.009. Epub 2018 Feb 5. Review.

12.

Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma.

Eberl M, Mangelberger D, Swanson JB, Verhaegen ME, Harms PW, Frohm ML, Dlugosz AA, Wong SY.

Cancer Cell. 2018 Feb 12;33(2):229-243.e4. doi: 10.1016/j.ccell.2017.12.015. Epub 2018 Jan 27.

13.

[Accidental poisoning with aconite napel (monkshood) : Simultaneous treatment of two patients].

Eberl M, Seidel M.

Med Klin Intensivmed Notfmed. 2018 Oct;113(7):574-576. doi: 10.1007/s00063-017-0388-4. Epub 2017 Dec 13. German.

PMID:
29236129
14.

Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network.

Aufricht C, Beelen R, Eberl M, Fischbach M, Fraser D, Jörres A, Kratochwill K, LópezCabrera M, Rutherford P, Schmitt CP, Topley N, Witowski J.

Kidney Int. 2017 Oct;92(4):824-835. doi: 10.1016/j.kint.2017.02.037. Epub 2017 Aug 8. Review.

PMID:
28797473
15.

Merkel Cell Polyomavirus Small T Antigen Initiates Merkel Cell Carcinoma-like Tumor Development in Mice.

Verhaegen ME, Mangelberger D, Harms PW, Eberl M, Wilbert DM, Meireles J, Bichakjian CK, Saunders TL, Wong SY, Dlugosz AA.

Cancer Res. 2017 Jun 15;77(12):3151-3157. doi: 10.1158/0008-5472.CAN-17-0035. Epub 2017 May 16.

16.

Coordination Behavior of [Cp''2 Zr(η1:1 -P4 )] towards Different Lewis Acids.

Seitz AE, Vogel U, Eberl M, Eckhardt M, Balázs G, Peresypkina EV, Bodensteiner M, Zabel M, Scheer M.

Chemistry. 2017 Aug 1;23(43):10319-10327. doi: 10.1002/chem.201701380. Epub 2017 Jun 23.

PMID:
28493497
17.

The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage Infection.

Howard J, Loizon S, Tyler CJ, Duluc D, Moser B, Mechain M, Duvignaud A, Malvy D, Troye-Blomberg M, Moreau JF, Eberl M, Mercereau-Puijalon O, Déchanet-Merville J, Behr C, Mamani-Matsuda M.

J Infect Dis. 2017 May 15;215(10):1569-1579. doi: 10.1093/infdis/jix149.

PMID:
28368498
18.

Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.

Chen HC, Joalland N, Bridgeman JS, Alchami FS, Jarry U, Khan MWA, Piggott L, Shanneik Y, Li J, Herold MJ, Herrmann T, Price DA, Gallimore AM, Clarkson RW, Scotet E, Moser B, Eberl M.

Immunol Cell Biol. 2017 Aug;95(7):620-629. doi: 10.1038/icb.2017.21. Epub 2017 Mar 30.

19.

Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of Calprotectin.

Tyler CJ, McCarthy NE, Lindsay JO, Stagg AJ, Moser B, Eberl M.

J Immunol. 2017 May 1;198(9):3417-3425. doi: 10.4049/jimmunol.1700003. Epub 2017 Mar 22.

20.

Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections.

Zhang J, Friberg IM, Kift-Morgan A, Parekh G, Morgan MP, Liuzzi AR, Lin CY, Donovan KL, Colmont CS, Morgan PH, Davis P, Weeks I, Fraser DJ, Topley N, Eberl M.

Kidney Int. 2017 Jul;92(1):179-191. doi: 10.1016/j.kint.2017.01.017. Epub 2017 Mar 17.

21.

Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling.

Liuzzi AR, Kift-Morgan A, Lopez-Anton M, Friberg IM, Zhang J, Brook AC, Roberts GW, Donovan KL, Colmont CS, Toleman MA, Bowen T, Johnson DW, Topley N, Moser B, Fraser DJ, Eberl M.

J Immunol. 2016 Sep 15;197(6):2195-207. doi: 10.4049/jimmunol.1600990. Epub 2016 Aug 15.

22.

Probiotic Lactobacilli Modulate Staphylococcus aureus-Induced Activation of Conventional and Unconventional T cells and NK Cells.

Johansson MA, Björkander S, Mata Forsberg M, Qazi KR, Salvany Celades M, Bittmann J, Eberl M, Sverremark-Ekström E.

Front Immunol. 2016 Jul 11;7:273. doi: 10.3389/fimmu.2016.00273. eCollection 2016.

23.

Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Raby AC, Colmont CS, Kift-Morgan A, Köhl J, Eberl M, Fraser D, Topley N, Labéta MO.

J Am Soc Nephrol. 2017 Feb;28(2):461-478. doi: 10.1681/ASN.2015080923. Epub 2016 Jul 18.

24.

The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.

Nivarthi H, Gordziel C, Themanns M, Kramer N, Eberl M, Rabe B, Schlederer M, Rose-John S, Knösel T, Kenner L, Freund P, Aberger F, Han X, Kralovics R, Dolznig H, Jennek S, Friedrich K, Moriggl R.

Oncotarget. 2016 Aug 9;7(32):51096-51106. doi: 10.18632/oncotarget.9315. Erratum in: Oncotarget. 2018 Sep 18;9(73):33865.

25.

Sepsis Patients with First and Second-Hit Infections Show Different Outcomes Depending on the Causative Organism.

Morgan MP, Szakmany T, Power SG, Olaniyi P, Hall JE, Rowan K, Eberl M.

Front Microbiol. 2016 Feb 26;7:207. doi: 10.3389/fmicb.2016.00207. eCollection 2016.

26.

Early innate responses to pathogens: pattern recognition by unconventional human T-cells.

Liuzzi AR, McLaren JE, Price DA, Eberl M.

Curr Opin Immunol. 2015 Oct;36:31-7. doi: 10.1016/j.coi.2015.06.002. Epub 2015 Jul 13. Review.

27.

Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

Piggott L, Omidvar N, Martí Pérez S, French R, Eberl M, Clarkson RW.

Breast Cancer Res. 2015 Jul 16;17:96. doi: 10.1186/s13058-015-0597-9. No abstract available.

28.

Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches.

Peterson SC, Eberl M, Vagnozzi AN, Belkadi A, Veniaminova NA, Verhaegen ME, Bichakjian CK, Ward NL, Dlugosz AA, Wong SY.

Cell Stem Cell. 2015 Apr 2;16(4):400-12. doi: 10.1016/j.stem.2015.02.006.

29.

Human Vγ9/Vδ2 T cells: Innate adaptors of the immune system.

Tyler CJ, Doherty DG, Moser B, Eberl M.

Cell Immunol. 2015 Jul;296(1):10-21. doi: 10.1016/j.cellimm.2015.01.008. Epub 2015 Jan 28. Review.

PMID:
25659480
30.

Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.

Rhodes DA, Chen HC, Price AJ, Keeble AH, Davey MS, James LC, Eberl M, Trowsdale J.

J Immunol. 2015 Mar 1;194(5):2390-8. doi: 10.4049/jimmunol.1401064. Epub 2015 Jan 30.

31.

Chicago 2014--30 years of γδ T cells.

Bonneville M, Chen ZW, Déchanet-Merville J, Eberl M, Fournié JJ, Jameson JM, Lopez RD, Massaia M, Silva-Santos B.

Cell Immunol. 2015 Jul;296(1):3-9. doi: 10.1016/j.cellimm.2014.11.001. Epub 2014 Nov 8.

32.

Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells.

Eberl M, Friberg IM, Liuzzi AR, Morgan MP, Topley N.

Front Immunol. 2014 Nov 13;5:572. doi: 10.3389/fimmu.2014.00572. eCollection 2014. Review. No abstract available.

33.

Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy.

Khan MW, Eberl M, Moser B.

Front Immunol. 2014 Oct 21;5:512. doi: 10.3389/fimmu.2014.00512. eCollection 2014. Review.

34.

Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells.

Davey MS, Morgan MP, Liuzzi AR, Tyler CJ, Khan MWA, Szakmany T, Hall JE, Moser B, Eberl M.

J Immunol. 2014 Oct 1;193(7):3704-3716. doi: 10.4049/jimmunol.1401018. Epub 2014 Aug 27.

35.

Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions.

Khan MW, Curbishley SM, Chen HC, Thomas AD, Pircher H, Mavilio D, Steven NM, Eberl M, Moser B.

Front Immunol. 2014 Jul 23;5:344. doi: 10.3389/fimmu.2014.00344. eCollection 2014.

36.

Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients.

Lin CY, Roberts GW, Kift-Morgan A, Donovan KL, Topley N, Eberl M.

J Am Soc Nephrol. 2013 Dec;24(12):2002-9. doi: 10.1681/ASN.2013040332. Epub 2013 Oct 31.

37.

An unconventional TRAIL to cancer therapy.

Chen HC, Dieli F, Eberl M.

Eur J Immunol. 2013 Dec;43(12):3159-62. doi: 10.1002/eji.201344105. Epub 2013 Nov 4.

38.

γδ T cells predict outcome in zoledronate-treated breast cancer patients.

Welton JL, Martí S, Mahdi MH, Boobier C, Barrett-Lee PJ, Eberl M.

Oncologist. 2013;18(8):e22-3. doi: 10.1634/theoncologist.2013-0097. No abstract available.

39.

Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1.

Götschel F, Berg D, Gruber W, Bender C, Eberl M, Friedel M, Sonntag J, Rüngeler E, Hache H, Wierling C, Nietfeld W, Lehrach H, Frischauf A, Schwartz-Albiez R, Aberger F, Korf U.

PLoS One. 2013 Jun 10;8(6):e65403. doi: 10.1371/journal.pone.0065403. Print 2013.

40.

Suppression of pro-inflammatory T-cell responses by human mesothelial cells.

Lin CY, Kift-Morgan A, Moser B, Topley N, Eberl M.

Nephrol Dial Transplant. 2013 Jul;28(7):1743-50. doi: 10.1093/ndt/gfs612. Epub 2013 Jan 25.

PMID:
23355626
41.

γδ T-cell conference 2012: close encounters for the fifth time.

Silva-Santos B, Schamel WW, Fisch P, Eberl M.

Eur J Immunol. 2012 Dec;42(12):3101-5. doi: 10.1002/eji.201270101. Erratum in: Eur J Immunol. 2013 Feb;43(2):562.

42.

Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.

Welton JL, Morgan MP, Martí S, Stone MD, Moser B, Sewell AK, Turton J, Eberl M.

J Bone Miner Res. 2013 Mar;28(3):464-71. doi: 10.1002/jbmr.1797.

43.

Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators?

Riganti C, Massaia M, Davey MS, Eberl M.

Eur J Immunol. 2012 Jul;42(7):1668-76. doi: 10.1002/eji.201242492. Review.

44.

HmgR, a key enzyme in the mevalonate pathway for isoprenoid biosynthesis, is essential for growth of Listeria monocytogenes EGDe.

Heuston S, Begley M, Davey MS, Eberl M, Casey PG, Hill C, Gahan CG.

Microbiology. 2012 Jul;158(Pt 7):1684-93. doi: 10.1099/mic.0.056069-0. Epub 2012 Apr 13.

PMID:
22504435
45.

Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells.

Eberl M, Klingler S, Mangelberger D, Loipetzberger A, Damhofer H, Zoidl K, Schnidar H, Hache H, Bauer HC, Solca F, Hauser-Kronberger C, Ermilov AN, Verhaegen ME, Bichakjian CK, Dlugosz AA, Nietfeld W, Sibilia M, Lehrach H, Wierling C, Aberger F.

EMBO Mol Med. 2012 Mar;4(3):218-33. doi: 10.1002/emmm.201100201. Epub 2012 Feb 1.

46.

Cooperative Hedgehog-EGFR signaling.

Mangelberger D, Kern D, Loipetzberger A, Eberl M, Aberger F.

Front Biosci (Landmark Ed). 2012 Jan 1;17:90-9. Review.

47.

Failure to detect production of IL-10 by activated human neutrophils.

Davey MS, Tamassia N, Rossato M, Bazzoni F, Calzetti F, Bruderek K, Sironi M, Zimmer L, Bottazzi B, Mantovani A, Brandau S, Moser B, Eberl M, Cassatella MA.

Nat Immunol. 2011 Oct 19;12(11):1017-8; author reply 1018-20. doi: 10.1038/ni.2111. No abstract available.

PMID:
22012430
48.

IL-21 enhances the potential of human γδ T cells to provide B-cell help.

Bansal RR, Mackay CR, Moser B, Eberl M.

Eur J Immunol. 2012 Jan;42(1):110-9. doi: 10.1002/eji.201142017. Epub 2011 Dec 12.

49.

Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

Piggott L, Omidvar N, Martí Pérez S, French R, Eberl M, Clarkson RW.

Breast Cancer Res. 2011 Sep 14;13(5):R88. doi: 10.1186/bcr2945. Erratum in: Breast Cancer Res. 2015;17:96. French, Rhiannon [added].

50.

Access to phosphorus-rich zirconium complexes.

Vogel U, Eberl M, Eckhardt M, Seitz A, Rummel EM, Timoshkin AY, Peresypkina EV, Scheer M.

Angew Chem Int Ed Engl. 2011 Sep 12;50(38):8982-5. doi: 10.1002/anie.201103634. Epub 2011 Aug 24. No abstract available.

PMID:
21901800

Supplemental Content

Support Center